This webinar will be hosted live and available on-demand
Thursday, October 12, 2023
2:30-3:30 PM Eastern Time
Chimeric antigen receptor T (CAR T) cell therapy is a groundbreaking immunotherapy used to treat cancer. After genetic modification and purification of the patient-derived T cells, researchers need to expand the cell population before they administer them back into the patient. This expansion process can take up to 3 weeks, all while the patient is awaiting treatment.
In this webinar brought to you by Miltenyi Biotec, Chris Ashdown will discuss how low-intensity vibration may be the key to accelerating CAR T production and improving its effectiveness in patients.
Topics to be covered
- Introduction to low-intensity vibration
- The effect of low-intensity vibration on T cells
- How low-intensity vibration improves CAR T manufacturing and efficacy
 | Christopher Ashdown |
